-
Fmr. MedMen CEO Adam Bierman Breaks The Silence: 'We Were Doing Things For The First Time, Inevitably Pissing People Off'
Thursday, January 27, 2022 - 1:18pm | 3585Read More...Adam Bierman and Andrew Modlin founded MedMen (OTC: MMNFF) in 2010. Since then the company, which started with a single store in California, skyrocketed off the technical graphs, becoming the first mainstream cannabis company in the world to hit every screen in America. The kickstart of...
-
Ousted MedMen Executives File Suit Against Their Own Company
Tuesday, October 5, 2021 - 4:49pm | 391Read More...A company run by the ousted co-founders of cannabis giant MedMen (OTC: MMNFF), Adam Bierman and Andrew Modlin, are suing Coastal Holding Co., a company that holds several cannabis licenses in multiple California cities, over planning to sell the company for $56.2 million, reported Law360. The...
-
Adam Bierman Steps Down As MedMen CEO, Stock Trades Higher
Friday, January 31, 2020 - 11:37am | 433Read More...MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) announced Friday that CEO Adam Bierman is stepping down from the role effective Feb. 1. Ryan Lissack, the cannabis company's chief operating officer and chief technology officer, has been named interim CEO. Bierman To Surrender Class A...
-
Exclusive: MedMen CEO Talks Pharmacann M&A Termination, CFO Change
Tuesday, October 8, 2019 - 6:01am | 816Read More...MedMen Enterprises Inc (OTC: MMNFF) (CSE: MMEN) announced Tuesday it has terminated the deal to acquire multi-state cannabis operator Pharmacann. The company is also terminating its chief financial officer, Michael Kramer. What Happened In a conversation with Benzinga, MedMen CEO Adam Bierman...
-
MedMen CEO Talks 'Blockbuster' PharmaCann Deal With Cramer
Tuesday, October 16, 2018 - 11:22am | 504Read More...Medmen Enterprises Inc (OTC: MMNFF) is a grower and retailer of marijuana that operates in California, Nevada and New York. On Tuesday Medmen CEO Adam Bierman was a guest on CNBC's "Mad Money" to discuss the company's "blockbuster" $682 million acquisition of PharmaCann...





